Clinical Pharmacology
Indications & Usage
OXCARBAZEPINE is listed as a SUSPENSION formulation in the SUSPENSION category. Consult official FDA labeling for full prescribing information.
Administration Context
OXCARBAZEPINE is administered via the ORAL route as a SUSPENSION.
Administration Protocol
Prescribing Information
Refer to official FDA labeling or institutional protocols for complete dosage and administration instructions.
Safety Profile
Contraindications & Warnings
Consult the official FDA-approved labeling for complete contraindications, warnings, precautions, and patient-specific safety information.
National Drug Registry
Product and label metadata.
Marketing Category
ANDA
Route of Administration
ORAL
National Drug Code
51672-1393
Manufacturer / Labeler
Sun Pharmaceutical Industries, Inc.
Dosage Form
SUSPENSION
Strength
See labeling
Application Number
ANDA078734
SPL Identifier
3bb99ec3-158e-4c64-e063-6294a90a6598
WHO Regulatory Intelligence
Vaccine Safety Information
Access evidence-based safety data and clinical guidelines from global health resources.